<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="173558">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00836563</url>
  </required_header>
  <id_info>
    <org_study_id>444-08-FB</org_study_id>
    <nct_id>NCT00836563</nct_id>
  </id_info>
  <brief_title>Vascular Changes Following Forearm Loop Arteriovenous Graft Placement</brief_title>
  <official_title>The Natural History of Upper Arm Vessels Following Forearm Loop Arteriovenous</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Nebraska</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Nebraska</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether upper arm vessels increase in size
      following forearm loop arteriovenous graft placement, and if they do, characterize the
      timing of these changes
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>50% increase in upper arm vein diameter</measure>
    <time_frame>Six months</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Forearm Arteriovenous Loop Graft</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing forearm arteriovenous loop graft placement
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Age greater than or equal to 19 years

          2. Planned forearm loop arteriovenous graft placement for hemodialysis or forearm loop
             arteriovenous graft placed within the previous 7 days.

          3. Cephalic and/or basilic vein diameter greater than or equal to 2.5 mm at the
             antecubital fossa to the axilla prior to AVG placement

        Exclusion Criteria:

          1. Age less than 19 years

          2. Hemodialysis access other than forearm loop graft surgery placement

          3. Cephalic and/or basilic vein diameter less than 2.5 mm at any point from the
             antecubital fossa to the axilla

          4. Prior hemodialysis access surgery in the arm receiving the forearm loop graft
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Troy J Plumb, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Nebraska</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>LuAnn Larson, RN, BSN</last_name>
    <phone>402-559-8555</phone>
    <email>llarson@unmc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>University of Nebraska Medical Center/The Nebraska Medical Center</name>
      <address>
        <city>Omaha</city>
        <state>Nebraska</state>
        <zip>68105</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>LuAnn Larson, RN, BSN</last_name>
      <phone>402-559-8555</phone>
      <email>llarson@unmc.edu</email>
    </contact>
    <investigator>
      <last_name>Troy J Plumb, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2010</verification_date>
  <lastchanged_date>July 15, 2010</lastchanged_date>
  <firstreceived_date>February 3, 2009</firstreceived_date>
  <responsible_party>
    <name_title>Troy J. Plumb, MD</name_title>
    <organization>University of Nebraska Medical Center</organization>
  </responsible_party>
  <keyword>Hemodialysis</keyword>
  <keyword>Arteriovenous Graft</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
